Table 2.
Associations with overall survival and clinicopathologic characteristics in TCGA BC patients using univariate (a) and multivariate Cox regression (b) analysis.
| Clinicopathologic variable | HR (95% CI) | P value |
|---|---|---|
| A | ||
| Age | 1.03 (1.00-1.06) | 0.039 |
| Gender | 0.63 (0.36-1.10) | 0.106 |
| Stage | 1.78 (1.24-2.54) | 0.007 |
| T | 1.69 (1.15-2.50) | 0.008 |
| M | 2.12 (0.76-5.88) | 0.15 |
| N | 1.55 (1.18-2.03) | 0.002 |
| PTPN6 | 0.59 (0.38-0.91) | 0.016 |
| B | ||
| Age | 1.02 (0.99-1.05) | 0.147 |
| Gender | 0.57 (0.31-1.02) | 0.059 |
| Stage | 1.18 (0.59-2.38) | 0.642 |
| T | 1.33 (0.81-2.20) | 0.259 |
| M | 1.17 (0.37-3.69) | 0.788 |
| N | 1.22 (0.73-2.04) | 0.459 |
| PTPN6 | 0.64 (0.40-1.02) | 0.06 |